Ronald Klein1. 1. Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, USA. kleinr@epi.ophth.wisc.edu
Abstract
PURPOSE: To provide an over-view of progress in the epidemiology of age-related macular degeneration. METHODS: Review of epidemiological and clinical trial findings regarding AMD since initial National Eye Institute sponsored epidemiology meeting in 1982. RESULTS: A growing number new epidemiological studies have provided data on the prevalence and long-term incidence of AMD. Despite a similar prevalence of early AMD in whites, blacks, and hispanics, whites have higher prevalence of late AMD. An age-period cohort effect has been shown in the Beaver Dam Eye Study suggesting that AMD incidence may be declining among younger birth cohorts. Genetic factors such as complement factor H have been shown to be strongly associated with AMD. Smoking is strongly related to risk of AMD. Randomized controlled clinical trials have shown the benefits of zinc-antioxidant supplementation in preventing visual loss in persons with signs of early AMD and anti-vascular endothelial growth factor agents in restoring vision in eyes with neovascular AMD. CONCLUSIONS: Despite remarkable progress in understanding AMD, many questions remain that can only be addressed by continuation of longitudinal population-based studies.
PURPOSE: To provide an over-view of progress in the epidemiology of age-related macular degeneration. METHODS: Review of epidemiological and clinical trial findings regarding AMD since initial National Eye Institute sponsored epidemiology meeting in 1982. RESULTS: A growing number new epidemiological studies have provided data on the prevalence and long-term incidence of AMD. Despite a similar prevalence of early AMD in whites, blacks, and hispanics, whites have higher prevalence of late AMD. An age-period cohort effect has been shown in the Beaver Dam Eye Study suggesting that AMD incidence may be declining among younger birth cohorts. Genetic factors such as complement factor H have been shown to be strongly associated with AMD. Smoking is strongly related to risk of AMD. Randomized controlled clinical trials have shown the benefits of zinc-antioxidant supplementation in preventing visual loss in persons with signs of early AMD and anti-vascular endothelial growth factor agents in restoring vision in eyes with neovascular AMD. CONCLUSIONS: Despite remarkable progress in understanding AMD, many questions remain that can only be addressed by continuation of longitudinal population-based studies.
Authors: Melissa K Jones; Bin Lu; Dawn Zhaohui Chen; Weston R Spivia; Augustus T Mercado; Alexander V Ljubimov; Clive N Svendsen; Jennifer E Van Eyk; Shaomei Wang Journal: Proteomics Date: 2019-01-02 Impact factor: 3.984
Authors: Zohar Yehoshua; Philip J Rosenfeld; Giovanni Gregori; William J Feuer; Manuel Falcão; Brandon J Lujan; Carmen Puliafito Journal: Ophthalmology Date: 2010-10-29 Impact factor: 12.079
Authors: Vincent T Ciavatta; Moon Kim; Paul Wong; John M Nickerson; R Keith Shuler; George Y McLean; Machelle T Pardue Journal: Invest Ophthalmol Vis Sci Date: 2009-03-05 Impact factor: 4.799
Authors: Chung-Jung Chiu; Paul Mitchell; Ronald Klein; Barbara E Klein; Min-Lee Chang; Gary Gensler; Allen Taylor Journal: Ophthalmology Date: 2014-03-18 Impact factor: 12.079
Authors: Bo Chang; Md Nawajes A Mandal; Venkata R M Chavali; Norman L Hawes; Naheed W Khan; Ronald E Hurd; Richard S Smith; Muriel L Davisson; Laura Kopplin; Barbara E K Klein; Ronald Klein; Sudha K Iyengar; John R Heckenlively; Radha Ayyagari Journal: Hum Mol Genet Date: 2008-09-18 Impact factor: 6.150